Investigators reported that CTX130 showed favorable preclinical proliferation and cytotoxicity profiles and completely regressed renal cell carcinoma xenograft tumors.
[Cancer Discovery]
Home Newsletters Cell Therapy News CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
